Rating Change
BTIG reiterated its Buy rating on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) on August 18, 2026.
reiterateNASDAQ:NRXP
BTIG Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
BTIG reiterated its Buy rating on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) on August 18, 2026.
At publication ·
What changed
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) · reiterate
- Firm
- BTIG
- Rating
- Buy to Buy
- Price at event
- $3.34
- Market capitalization
- $37.9M
At a glance
Key takeaways
- BTIG reiterated its Buy rating on NRx Pharmaceuticals (NRXP) on August 18, 2026, with the stock trading at $3.34 and a market capitalization of $37.9 million.
Market Context
NRx Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $3.34 with a market capitalization of $37.9M. The stock has gained 28.5% over the past 52 weeks.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for NRx Pharmaceuticals, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for NRx Pharmaceuticals, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 18, 2026 | BTIG | Buy | N/A |
| Aug 07, 2026 | BTIG | Buy | N/A |
| May 05, 2026 | D. Boral Capital | Buy | N/A |
| Apr 27, 2026 | HC Wainwright & Co. | Buy | N/A |
| Apr 27, 2026 | Ascendiant Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View NRXP Stock Page
Frequently Asked Questions
What does the Buy rating mean for NRXP?
A rating of Buy from BTIG reflects the analyst's outlook on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NRXP forecast page.